Intravitreal ranibizumab (Lucentis®) in the treatment of retinal angiomatous proliferation (RAP)

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 9, 2009, Pages 1165-1171

  Konstantinidis, Lazaros ^a   Mameletzi, Evangelia ^a   Mantel, Irmela ^a   Pournaras, Jean Antoine ^a   Zografos, Leonidas ^a   Ambresin, Aude ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Age related macular degeneration; Ranibizumab; Retinal angiomatous proliferation

Indexed keywords

RANIBIZUMAB;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETINAL ANGIOMATOUS PROLIFERATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANGIOMATOSIS; ANTIBODIES, MONOCLONAL; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; INJECTIONS; MACULAR DEGENERATION; MALE; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 68549088859     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1089-3     Document Type: Article

References (37)

1. Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D, Matsumoto Y, Sorenson JA, Yannuzzi L (2008) Type 3 neovascularization: The expanded spectrum of retinal angiomatous proliferation. Retina 28:201-211, doi: 10.1097/IAE.0b013e3181669504
2. Yannuzzi LA, Freund KB, Takahashi BS (2008) Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 28:375-384, doi: 10.1097/IAE.0b013e3181619c55
3. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, Freund KB, Sorenson J, Orlock D, Borodoker N (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416-434, doi: 10.1097/00006982-200110000-00003
4. Gross NE, Aizman A, Brucker A, Klancnik JM Jr, Yannuzzi LA (2005) Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 25:713-718, doi: 10.1097/00006982-200509000-00005
5. Bottoni F, Massacesi A, Cigada M, Viola F, Musicco I, Staurenghi G (2005) Treatment of retinal angiomatous proliferation in age-related macular degeneration: A series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123:1644-1650, doi: 10.1001/ archopht.123.12.1644
6. van de Moere A, Kak R, Sandhu SS, Talks SJ (2007) Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. Am J Ophthalmol 143:701-704, doi: 10.1016/j.ajo.2006.10.045
7. Shiragami C, Iida T, Nagayama D, Baba T, Shiraga F (2007) Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 27:198-203, doi: 10.1097/01.iae.0000224938.61915.f0
8. Rutishauser-Arnold Y, Tholen AM (2007) Periocular sub-tenon triamcinolone acetonide injections for the treatment of retinal angiomatous proliferation (rap) and occult choroidal neovascularisation. Klin Monatsbl Augenheilkd 224:269-273, doi: 10.1055/s-2006-927396
9. Roth DB, Scott IU, Gloth JM, Green SN, Yarian DL, Wheatley M (2007) Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation. Retina 27:1201-1204, doi: 10.1097/IAE.0b013e3180ed45a6
10. Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J, Garcia-Feijoo J, Saenz-Frances F, Fernandez-Perez C, Garcia-Sanchez J (2007) Retinal angiomatous proliferation reactivation 6 months after high-dose intravitreal acetonide triamcinolone and photodynamic therapy. Eur J Ophthalmol 17:979-982
11. Nicolo M, Ghiglione D, Lai S, Calabria G (2006) Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 244:1336-1338, doi: 10.1007/s00417-006-0306-6
12. Nakata M, Yuzawa M, Kawamura A, Shimada H (2006) Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 141:968-970, doi: 10.1016/j.ajo.2005.12.029
13. Mantel I, Ambresin A, Zografos L (2006) Retinal angiomatous proliferation treated with a combination of intravitreal triamcinolone acetonide and photodynamic therapy with verteporfin. Eur J Ophthalmol 16:705-710
14. Krieglstein TR, Kampik A, Ulbig M (2006) Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation. Br J Ophthalmol 90:1357-1360, doi: 10.1136/bjo.2006.092536
15. Klais CM, Eandi CM, Ober MD, Sorenson JA, Sadeghi SN, Freund KB, Spaide RF, Slakter JS, Yannuzzi LA (2006) Anecortave acetate treatment for retinal angiomatous proliferation: A pilot study. Retina 26:773-779, doi: 10.1097/01.iae.0000244261.52901.67
16. Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA, Yannuzzi LA (2006) Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124:487-492, doi: 10.1001/ archopht.124.4.487
17. Bottoni F, Romano M, Massacesi A, Bergamini F (2006) Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244:1528-1533, doi: 10.1007/s00417-006-0311-9
18. Boscia F, Parodi MB, Furino C, Reibaldi M, Sborgia C (2006) Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 244:1224-1232. doi: 10.1007/s00417-005-0205-2
19. Shimada H, Mori R, Arai K, Kawamura A, Yuzawa M (2005) Surgical excision of neovascularization in retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 243:519-524, doi: 10.1007/s00417-004-1073-x
20. Boscia F, Furino C, Prascina F, Delle Noci N, Sborgia L, Sborgia C (2005) Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angiomatous proliferation. Eur J Ophthalmol 15:513-516
21. Borrillo JL, Sivalingam A, Martidis A, Federman JL (2003) Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 121:558-561, doi: 10.1001/archopht.121.4.558
22. Kuroiwa S, Arai J, Gaun S, Iida T, Yoshimura N (2003) Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina 23:417-420, doi: 10.1097/ 00006982-200306000-00027
23. Shimada H, Kawamura A, Mori R, Yuzawa M (2007) Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245:295-300, doi: 10.1007/s00417-006-0367-6
24. Rakic JM, Lambert V, Devy L, Luttun A, Carmeliet P, Claes C, Nguyen L, Foidart JM, Noel A, Munaut C (2003) Placental growth factor, a member of the vegf family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3186-3193, doi: 10.1167/ iovs.02-1092
25. Otani A, Takagi H, Oh H, Koyama S, Ogura Y, Matumura M, Honda Y (2002) Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes. Microvasc Res 64:162-169, doi: 10.1006/mvre.2002.2407
26. Costagliola C, Romano MR, dell'Omo R, Cipollone U, Polisena P (2007) Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 144:449-451, doi: 10.1016/ j.ajo.2007.05.025
27. Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS, Klancnik JM Jr, Fisher YL, Cooney MJ, Yannuzzi LA (2007) Intravitreal bevacizumab (avastin) for retinal angiomatous proliferation. Retina 27:451-457, doi: 10.1097/IAE.0b013e318030ea80
28. Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS, Conway BP (2008) Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation. Retina 28:689-695, doi: 10.1097/IAE.0b013e318162d982
29. Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Saab M, Noureddin BN (2008) Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: A one-year prospective study. Am J Ophthalmol 145:249-256, doi: 10.1016/j.ajo.2007.09.031
30. Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM (2007) Bevacizumab (avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245:1597-1602, doi: 10.1007/ s00417-007-0580-y
31. Lai TY, Chan WM, Liu DT, Lam DS (2007) Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245:1877-1880, doi: 10.1007/s00417-007-0679-1
32. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419-1431, doi: 10.1056/NEJMoa054481
33. Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388-391
34. Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N (2008) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: Pier study year 1. Am J Ophthalmol 145:239-248 e235
35. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M (2007) An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143:566-583, doi: 10.1016/j.ajo.2007.01.028
36. Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A, Ladas ID (2009) Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: A prospective study. Retina 29:536-544
37. Forooghian F, Cukras C, Chew EY (2008) Retinal angiomatous proliferation complicated by pigment epithelial tear following intravitreal bevacizumab treatment. Can J Ophthalmol 43:246-248, doi: 10.3129/I08-017